GLP-1 medications have transformed the treatment of obesity and type 2 diabetes, but choosing between them isn't straightforward
this is a weekly injection through a pen that must be kept refrigerated
mass spectrometry-based methods have since confirmed circulating irisin in humans but at lower concentrations than initially reported (Perakakis et al., 2017)
As more generic, low-cost versions of Ozempic become available and medication innovations improve, I believe well see more solutions rolled out in the near future
Wegovy typically shows greater efficacy, though Contrave is suitable for those preferring an oral medication or who cannot tolerate GLP-1 receptor agonists
Association between participant characteristics and weight change Results of meta-regression indicated that the difference between participants including sex, age, indication, and BMI was not associated with the risk of weight regain, and the same is true of different control group